Prevalence of Renal Failure and Risk Factors in an Unreferred Healthy Population
Primary Purpose
Healthy
Status
Completed
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Taking blood sample
Sponsored by
About this trial
This is an interventional diagnostic trial for Healthy focused on measuring No specific condition
Eligibility Criteria
Inclusion Criteria: 20-55 years Male and female subjects
Sites / Locations
- University Hospital Ghent
Outcomes
Primary Outcome Measures
A possible association between renal clearance and found cardiovascular risk factors and risk factors by exposition to toxic substantia during work.
Secondary Outcome Measures
Full Information
NCT ID
NCT00365911
First Posted
August 17, 2006
Last Updated
June 1, 2011
Sponsor
University Hospital, Ghent
Collaborators
Prevemed-Medibo, Medical Laboratory CRI
1. Study Identification
Unique Protocol Identification Number
NCT00365911
Brief Title
Prevalence of Renal Failure and Risk Factors in an Unreferred Healthy Population
Official Title
Prevalence of Renal Failure and Risk Factors in an Unreferred Healthy Population
Study Type
Interventional
2. Study Status
Record Verification Date
June 2011
Overall Recruitment Status
Completed
Study Start Date
March 2006 (undefined)
Primary Completion Date
December 2009 (Actual)
Study Completion Date
December 2009 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
University Hospital, Ghent
Collaborators
Prevemed-Medibo, Medical Laboratory CRI
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Blood sample is taken for measurement of serum creatinine, cystatin C, clone V haemoglobin, cholesterol, urine acid, glycemia and CRP.
The medical file is gathered. There will be searched for an association between renal function and cardiovascular risk factors and risk factors by exposition to toxic substantia during work.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Healthy
Keywords
No specific condition
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
2000 (Anticipated)
8. Arms, Groups, and Interventions
Intervention Type
Procedure
Intervention Name(s)
Taking blood sample
Intervention Description
A blood sample will be taken.
Primary Outcome Measure Information:
Title
A possible association between renal clearance and found cardiovascular risk factors and risk factors by exposition to toxic substantia during work.
Time Frame
At time T0
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
20-55 years
Male and female subjects
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Raymond Vanholder, MD, PhD
Organizational Affiliation
University Hospital, Ghent
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Wim Van Biesen, MD, PhD
Organizational Affiliation
University Hospital, Ghent
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Ghent
City
Ghent
ZIP/Postal Code
9000
Country
Belgium
12. IPD Sharing Statement
Citations:
PubMed Identifier
20967254
Citation
van der Tol A, Van Biesen W, Verbeke F, De Groote G, Vermeiren F, Eeckhaut K, Vanholder R. Towards a rational screening strategy for albuminuria: results from the unreferred renal insufficiency trial. PLoS One. 2010 Oct 13;5(10):e13328. doi: 10.1371/journal.pone.0013328.
Results Reference
derived
Links:
URL
http://www.uzgent.be
Description
Website University Hospital Ghent
Learn more about this trial
Prevalence of Renal Failure and Risk Factors in an Unreferred Healthy Population
We'll reach out to this number within 24 hrs